These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 23034965)
1. Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. Itariu BK; Zeyda M; Hochbrugger EE; Neuhofer A; Prager G; Schindler K; Bohdjalian A; Mascher D; Vangala S; Schranz M; Krebs M; Bischof MG; Stulnig TM Am J Clin Nutr; 2012 Nov; 96(5):1137-49. PubMed ID: 23034965 [TBL] [Abstract][Full Text] [Related]
2. n3 PUFAs do not affect adipose tissue inflammation in overweight to moderately obese men and women. Kratz M; Kuzma JN; Hagman DK; van Yserloo B; Matthys CC; Callahan HS; Weigle DS J Nutr; 2013 Aug; 143(8):1340-7. PubMed ID: 23761646 [TBL] [Abstract][Full Text] [Related]
3. Treatment with n-3 polyunsaturated fatty acids overcomes the inverse association of vitamin D deficiency with inflammation in severely obese patients: a randomized controlled trial. Itariu BK; Zeyda M; Leitner L; Marculescu R; Stulnig TM PLoS One; 2013; 8(1):e54634. PubMed ID: 23372745 [TBL] [Abstract][Full Text] [Related]
4. Oral ω-3 PUFA supplementation modulates inflammation in adipose tissue depots in morbidly obese women: A randomized trial. Bakker N; Hickey M; Shams R; Rivera CF; Vlahos J; Cense HA; Demirkiran A; Ramkhelawon B; Houdijk AP Nutrition; 2023 Jul; 111():112055. PubMed ID: 37182400 [TBL] [Abstract][Full Text] [Related]
5. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Bjermo H; Iggman D; Kullberg J; Dahlman I; Johansson L; Persson L; Berglund J; Pulkki K; Basu S; Uusitupa M; Rudling M; Arner P; Cederholm T; Ahlström H; Risérus U Am J Clin Nutr; 2012 May; 95(5):1003-12. PubMed ID: 22492369 [TBL] [Abstract][Full Text] [Related]
6. Differential dose effect of fish oil on inflammation and adipose tissue gene expression in chronic kidney disease patients. Guebre-Egziabher F; Debard C; Drai J; Denis L; Pesenti S; Bienvenu J; Vidal H; Laville M; Fouque D Nutrition; 2013 May; 29(5):730-6. PubMed ID: 23375525 [TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition. Yee LD; Lester JL; Cole RM; Richardson JR; Hsu JC; Li Y; Lehman A; Belury MA; Clinton SK Am J Clin Nutr; 2010 May; 91(5):1185-94. PubMed ID: 20335550 [TBL] [Abstract][Full Text] [Related]
8. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study. Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722 [TBL] [Abstract][Full Text] [Related]
9. Modification of subcutaneous white adipose tissue inflammation by omega-3 fatty acids is limited in human obesity-a double blind, randomised clinical trial. Fisk HL; Childs CE; Miles EA; Ayres R; Noakes PS; Paras-Chavez C; Kuda O; Kopecký J; Antoun E; Lillycrop KA; Calder PC EBioMedicine; 2022 Mar; 77():103909. PubMed ID: 35247847 [TBL] [Abstract][Full Text] [Related]
10. Impact of polyunsaturated and saturated fat overfeeding on the DNA-methylation pattern in human adipose tissue: a randomized controlled trial. Perfilyev A; Dahlman I; Gillberg L; Rosqvist F; Iggman D; Volkov P; Nilsson E; Risérus U; Ling C Am J Clin Nutr; 2017 Apr; 105(4):991-1000. PubMed ID: 28275132 [No Abstract] [Full Text] [Related]
11. A combination of Omega-3 PUFAs and COX inhibitors: A novel strategy to manage obesity-linked dyslipidemia and adipose tissue inflammation. Saraswathi V; Heineman R; Alnouti Y; Shivaswamy V; Desouza CV J Diabetes Complications; 2020 Feb; 34(2):107494. PubMed ID: 31787562 [TBL] [Abstract][Full Text] [Related]
12. Dysregulation of Subcutaneous White Adipose Tissue Inflammatory Environment Modelling in Non-Insulin Resistant Obesity and Responses to Omega-3 Fatty Acids - A Double Blind, Randomised Clinical Trial. Fisk HL; Childs CE; Miles EA; Ayres R; Noakes PS; Paras-Chavez C; Antoun E; Lillycrop KA; Calder PC Front Immunol; 2022; 13():922654. PubMed ID: 35958557 [TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. Martínez-Fernández L; Laiglesia LM; Huerta AE; Martínez JA; Moreno-Aliaga MJ Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):24-41. PubMed ID: 26219838 [TBL] [Abstract][Full Text] [Related]
14. Dietary Omega-3 Fatty Acid Supplementation Reduces Inflammation in Obese Pregnant Women: A Randomized Double-Blind Controlled Clinical Trial. Haghiac M; Yang XH; Presley L; Smith S; Dettelback S; Minium J; Belury MA; Catalano PM; Hauguel-de Mouzon S PLoS One; 2015; 10(9):e0137309. PubMed ID: 26340264 [TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production. Polus A; Zapala B; Razny U; Gielicz A; Kiec-Wilk B; Malczewska-Malec M; Sanak M; Childs CE; Calder PC; Dembinska-Kiec A Biochim Biophys Acta; 2016 Nov; 1861(11):1746-1755. PubMed ID: 27531277 [TBL] [Abstract][Full Text] [Related]
16. Energy-restricted, n-3 polyunsaturated fatty acids-rich diet improves the clinical response to immuno-modulating drugs in obese patients with plaque-type psoriasis: a randomized control clinical trial. Guida B; Napoleone A; Trio R; Nastasi A; Balato N; Laccetti R; Cataldi M Clin Nutr; 2014 Jun; 33(3):399-405. PubMed ID: 24120032 [TBL] [Abstract][Full Text] [Related]
17. PPARγ2 Pro12Ala polymorphism is associated with improved lipoprotein lipase functioning in adipose tissue of insulin resistant obese women. López-Alarcón M; Rodríguez-Cruz M; Vital-Reyes VS; Zavala-Ortega MI; Hinojosa-Cruz JC; Canizales-Quinteros S; Fernández J Gene; 2012 Dec; 511(2):404-10. PubMed ID: 23036713 [TBL] [Abstract][Full Text] [Related]
18. Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial. Rodríguez-Cruz M; Cruz-Guzmán ODR; Almeida-Becerril T; Solís-Serna AD; Atilano-Miguel S; Sánchez-González JR; Barbosa-Cortés L; Ruíz-Cruz ED; Huicochea JC; Cárdenas-Conejo A; Escobar-Cedillo RE; Yam-Ontiveros CA; Ricárdez-Marcial EF Clin Nutr; 2018 Dec; 37(6 Pt A):1840-1851. PubMed ID: 28987470 [TBL] [Abstract][Full Text] [Related]
19. Very-long-chain Hames KC; Morgan-Bathke M; Harteneck DA; Zhou L; Port JD; Lanza IR; Jensen MD Am J Clin Nutr; 2017 Jun; 105(6):1552-1558. PubMed ID: 28424185 [No Abstract] [Full Text] [Related]
20. The consumption of n-3 polyunsaturated fatty acids differentially modulates gene expression of peroxisome proliferator-activated receptor alpha and gamma and hypoxia-inducible factor 1 alpha in subcutaneous adipose tissue of obese adolescents. Mejía-Barradas CM; Del-Río-Navarro BE; Domínguez-López A; Campos-Rodríguez R; Martínez-Godínez Md; Rojas-Hernández S; Lara-Padilla E; Abarca-Rojano E; Miliar-García Á Endocrine; 2014 Feb; 45(1):98-105. PubMed ID: 23546614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]